The allegations concerning Elon Musk’s personal use of ketamine and other substances should be viewed with caution and ...
A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...
Legislation requiring healthcare professionals assess a woman for postpartum depression made it over the first hurdles last week by getting approval from Senate ...
KHQA on MSN19h
Blessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Medical Device Network on MSN1d
Sooma gains FDA approval to commence study of tDCS deviceSooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...
Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in life.
Sooma Oy secured U.S. FDA investigational device exemption approval to initiate a pivotal study of its transcranial direct ...
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
Sooma announced that it received FDA investigational device exemption (IDE) for its transcranial direct current stimulation ...
The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...
This summary highlights key global health developments, including J&J halting studies of a depression drug due to low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback